Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats

Neuroscience Letters

Volumn 490, Issue 3, 2011, Pages 191-195

  Bloms Funke, P ^a   Dremencov, E ^b   Cremers, T I F H ^b   Tzschentke, T M ^a  

^a GRÜNENTHAL GMBH   (Germany)

^b CHARLES RIVER LABORATORIES   (United States)

Author keywords

Brain; Microdialysis; Noradrenaline; Rat; Serotonin; Tramadol

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DULOXETINE; NORADRENALIN; REBOXETINE; SEROTONIN; TRAMADOL; VENLAFAXINE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; HIPPOCAMPUS; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; HIPPOCAMPUS; MALE; MICRODIALYSIS; NARCOTICS; NOREPINEPHRINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TRAMADOL; WAKEFULNESS;

EID: 79551575209     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.12.049     Document Type: Article

References (29)

1. Bamigbade T.A., Davidson C., Langford R.M., Stamford J.A. Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. Br. J. Anaesth. 1997, 79:352-356.
2. Béïque J.-C., de Montigny C., Blier P., Debonnel G. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. Br. J. Pharmacol. 1998, 125:526-532.
3. Béïque J.-C., Lavoie N., de Montigny C., Debonnel G. Affinities of venlafaxine and various inhibitors for the serotonin and norepinephrine transporters. Eur. J. Pharmacol. 1998, 349:129-132.
4. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur. Neuropsychopharmacol. 2003, 13:57-66.
5. Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., Shaw J.L., Thompson L., Nelson D.L., Hemrick-Luecke S.K., Wong D.T. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in-vitro and in-vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001, 25:871-880.
6. Cremers T.I.F.H, Rea K., Bosker F.J., Wikström H.V., Hogg S., Mork A., Westerink B.H.C. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology 2007, 32:1550-1557.
7. Desmeules J.A., Piguet V., Collart L., Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br. J. Clin. Pharmacol. 1996, 41:7-12.
8. Dremencov E., El Mansari M., Blier P. Brain norepinephrine system as a target for antidepressant and mood stabilizing medications. Curr. Drug Targets 2009, 10:1061-1068.
9. Driessen B., Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br. J. Pharmacol. 1992, 105:147-151.
10. Driessen B, Reimann W., Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br. J. Pharmacol. 1993, 108:806-811.
11. Frink M.C., Hennies H.H., Englberger W., Haurand M., Wilffert B. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneim. Forsch./Drug Res. 1996, 46:1029-1036.
12. Halfpenny D.M., Callado L.F., Hopwood S.E., Bamigbade T.A., Langford R.M., Stamford J.A. Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real time voltammetry. Br. J. Anaesth. 1999, 83:909-915.
13. Kirchheiner J., Keulen J.T., Bauer S., Roots I., Brockmöller J. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J. Clin. Psychopharmacol. 2008, 28:78-83.
14. Koch S., Hemrick-Luecke S.K., Thompson L.K., Evans D.C., Threlkeld P.G., Nelson D.L., Perry K.W., Bymaster F.P. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats. Neuropharmacology 2003, 45:935-944.
15. Matsumoto M., Yoshioka M., Togashi H., Hirokami M., Tochihara M., Ikeda T., Smith C.B. mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis. Brain Res. 1994, 636:1-8.
16. Millan M.J, Gobert A., Lejeune F., Newman-Tancredi A., Rivet J.-M., Auclair A., Peglion J.-L. S33005, a novel ligand at both serotonin and norepinephrine transporters. I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J. Pharmacol. Exp. Ther. 2001, 298:565-580.
17. Munro G., Baek C.A., Erichsen H.K., Nielsen A.N., Nielsen E.O., Scheel-Krüger J., Weikop P., Peters D. The novel compound (±)-1-[10-((E)-3-phenyl-allyl)-3, 10-diaza-bicyclo[4. 3. 1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined μ-opoid receptor agonist and monoamine reuptake inhibitor tramadol. Neuropharmacology 2008, 54:331-343.
18. Oliva P., Aurilio C., Massimo F., Grella A., Maione S., Grella E., Scafuro M., Rossi F., Berrino L. The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. Eur. J. Pharmacol. 2002, 445:179-185.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1982, Academic Press, New York.
20. Raffa R.B., Friderichs E. The basic science aspect of tramadol hydrochloride. Pain Rev. 1996, 3:249-271.
21. Raffa R.B., Nayak R.K., Liao S., Minn F.L. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Rev. Contemp. Pharmacother. 1995, 6:485-497.
22. Reeves R.R., Burke R.S. Tramadol: basic pharmacology and emerging concepts. Drugs Today 2008, 44:827-836.
23. Sevcik J., Nieber K., Driessen B., Illes P. Effects of the central analgesic tramadol and its major metabolite, O-desmethyltramadol, on rat locus coeruleus neurons. Br. J. Pharmacol. 1993, 110:169-176.
24. Sprague J.E, Leifheit M., Selken J., Milks M.M., Kinder D.H., Nichols D.E. In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Synapse 2002, 43:118-121.
25. Tao R., Auerbach S.B. Anesthetics block morphine-induced increases in serotonin release in rat CNS. Synapse 1994, 18:307-314.
26. Tao R., Auerbach S.B. Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience 1995, 68:553-561.
27. Tao R., Auerbach S.B. GABAergic glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system. J. Pharmacol. Exp. Ther. 2002, 303:704-710.
28. Tzschentke T.M., Christoph T., Kögel B., Schiene K., Hennies H.-H., Englberger W., Haurand M., Jahnel U., Cremers T.I.F.H., Friderichs E., De Vry J. (-)-(1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel μ-opioid receptor agonist/norepinephrine re-uptake inhibitor with broad-spectrum analgesic properties. J. Pharmacol. Exp. Ther. 2007, 323:265-276.
29. Yoshioka M., Matsumoto M., Togashi H., Smith C.B., Saito H. Opioid receptor regulation of 5-hydroxytryptamine release from the rat hippocampus measured by in vivo microdialysis. Brain Res. 1993, 613:74-79.